Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis

Internal Medicine Journal

Volumn 35, Issue 10, 2005, Pages 638-640

  Anandacoomarasamy, A ^a   Kannangara, S ^a   Barnsley, L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIHISTAMINIC AGENT; ANTINUCLEAR ANTIBODY; CALCIUM; CELL ANTIGEN; CELL NUCLEUS ANTIGEN; CYANOCOBALAMIN; DOUBLE STRANDED DNA; ENALAPRIL; EXTRACTABLE NUCLEAR ANTIGEN; FOLIC ACID; GOLD; INFLIXIMAB; ISONIAZID; METHOTREXATE; PREDNISONE; PYRIDOXINE; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ANTIBODY TITER; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMORBIDITY; DIARRHEA; DISEASE CONTROL; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG WITHDRAWAL; EDEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LABORATORY TEST; LEUCOCYTOCLASTIC VASCULITIS; LIVEDO RETICULARIS; NAUSEA; PERNICIOUS ANEMIA; PRIORITY JOURNAL; PURPURA; RASH; RHEUMATOID ARTHRITIS; SEROPREVALENCE; SKIN BIOPSY; SYNOVITIS; TUBERCULOSIS; VASCULITIS; VOMITING;

EID: 27644462725     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00899.x     Document Type: Article

References (10)

1. Weisman MH. What are the risks of biologic therapy in rheumatoid arthritis? An update on safety. J Rheumatol Suppl 2002; 65: 33-8.
2. Favalli EG, Sinigaglia L, Varenna M, Arnoldi C. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Lupus 2002; 11: 753-5.
3. Mohan AK, Edwards ET, Cote TR, Siegel JN, Braun MM. Drug-induced systemic lupus erythematosus and TNF-alpha blockers. Lancet 2002; 360: 646.
4. Debandt M, Vittecoq O, Descamps V, Le LX, Meyer O. Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol 2003; 22: 56-61.
5. McCain ME, Quinet RJ, Davis WE. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology (Oxford) 2002; 41: 116-17.
6. McIlwain L, Carter JD, Bin-Sagheer S, Vasey FB, Nord J. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. J Clin Gastroenterol 2003; 36: 411-13.
7. Devos SABN, De Vos M, Naeyaert JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology 2003; 206: 388-90.
8. Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN et al. Leucocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004; 31: 1955-8.
9. Halevy S, Giryes H, Avinoach I, Livni E, Sukenik S. Leukocytoclastic vasculitis induced by low-dose methotrexate: in vitro evidence for an immunologic mechanism. J Eur Acad Dermatol Venereol 1998; 10: 81-5.
10. Doyle MK, Cuellar ML. Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2: 401-9.